Clinical Trials Sponsored by Robert Ferris

Total 2469 results

Ferring Pharmaceuticals

Completed

Safety and Efficacy of Firmagon® (Degarelix) for Injection

Prostate Cancer

Korea, Republic of
Ferring Pharmaceuticals

Completed

A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility

Infertility

Korea, Republic of
Ferring Pharmaceuticals

Terminated

Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome (RAZANT)

Growth Disorders

Germany
Ferring Pharmaceuticals

Completed

Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina (FAST AR)

Advanced Hormone Dependent Prostate Cancer

Argentina
Ferring Pharmaceuticals

Completed

Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy (Prepopik PREA)

Need for Bowel Preparation

United States
Ferring Pharmaceuticals

Completed

Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

Advanced Hormone Sensitive Prostate Cancer

Netherlands
Ferring Pharmaceuticals

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel

Adult Male Hypogonadism

United States, Canada
Ferring Pharmaceuticals

Completed

A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator

Hypogonadal Males

United States
Ferring Pharmaceuticals

Completed

Efficacy, Pharmacokinetics and Safety of Testosterone

Testicular Hypogonadism

United States
Ferring Pharmaceuticals

Completed

A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing

Colon Cleansing in Preparation for Colonoscopy

Japan
Ferring Pharmaceuticals

Completed

Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions (OVANCON)

In Vitro Fertilisation (IVF) Treatment

Belgium, Czechia, Spain
Ferring Pharmaceuticals

Completed

A Study of Degarelix in Patients With Prostate Cancer

Prostate Cancer

United States
Ferring Pharmaceuticals

Completed

REgistry of MisOprostol 200 µg Vaginal dElivery System (REMOVE)

Induction of Labour

Netherlands
Ferring Pharmaceuticals

Completed

Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females

Infertility

United States
Ferring Pharmaceuticals

Completed

A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer (FAST-NL)

Prostate Cancer

Netherlands
Ferring Pharmaceuticals

Completed

One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population (PANDA)

Prostate Cancer

China
Ferring Pharmaceuticals

Completed

Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (BASIC)

Infertility

Belgium, Spain, Australia, Canada, Czech Republic, Poland
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) (DELUTS)

Lower Urinary Tract Symptoms (LUTS)

United States, Canada, Belgium, Czech Republic, Italy, Poland
Ferring Pharmaceuticals

Completed

Efficacy and Safety of XP12B in Women With Menorrhagia

Menorrhagia | Heavy Menstrual Bleeding

United States
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Patients With Prostate Cancer

Prostate Cancer

United States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
Ferring Pharmaceuticals

Completed

Menopur Mixed Protocol (COMBINE)

Infertility

United States
Ferring Pharmaceuticals

Completed

Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

Induction of Labor | Cervical Ripening

United States
Ferring Pharmaceuticals

Completed

Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to Hysteroscopy

Cervical Priming

United States
Ferring Pharmaceuticals

Completed

Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer (IM1)

Prostate Cancer

United States, Canada
Ferring Pharmaceuticals

Completed

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Ulcerative Colitis

Czech Republic
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women (NOC)

Nocturia

Japan
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Patients With Nocturia

Nocturia

Czech Republic
Ferring Pharmaceuticals

Completed

Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)

Crohn's Disease

United States
Ferring Pharmaceuticals

Completed

Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding (PREA)

Menorrhagia

United States
Ferring Pharmaceuticals

Completed

Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Ferring Pharmaceuticals

Completed

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo (NOC)

Nocturia

Japan
Ferring Pharmaceuticals

Completed

MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer (MEGASET)

Infertility

Turkey, Belgium, Spain, Poland, Czech Republic, Denmark, Sweden
Ferring Pharmaceuticals

Completed

Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

Infertility, Female

Belgium, Czech Republic, Spain
Ferring Pharmaceuticals

Terminated

Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients

Prostate Cancer
Ferring Pharmaceuticals

Completed

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

Turner's Syndrome

Czech Republic, France, Netherlands
Ferring Pharmaceuticals

Completed

Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC

Osteoarthritis

United States
Ferring Pharmaceuticals

Completed

A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) (PALAT)

Primary Nocturnal Enuresis

France
Ferring Pharmaceuticals

Completed

A Study of Pentasa in Patients With Ulcerative Colitis

Ulcerative Colitis

Czech Republic
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer

Prostate Cancer

Korea, Republic of
Robert Flavell, MD, PhD
United States Department of Defense; Fortis Therapeutics, Inc.

Recruiting

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

United States
Ferring Pharmaceuticals
Ferring Pharmaceuticals Korea, Ltd.

Completed

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Prostate Cancer

Korea, Republic of
Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
Ferring Pharmaceuticals

Recruiting

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States (ABLE-41)

Bladder Cancer

United States
Ferring Pharmaceuticals

Recruiting

REBYOTA™ Prospective Registry (ROAR)

Recurrence of Clostridium Difficile Infection

United States
Ferring Pharmaceuticals

Recruiting

Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer

Japan
Ferring Pharmaceuticals

Recruiting

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PICCOLO)

Bowel Preparation

United States
Ferring Pharmaceuticals

Completed

Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) (BEYOND)

Infertility, Female

Norway, Israel, Denmark, Netherlands, Italy, Austria, Switzerland
Ferring Pharmaceuticals

Completed

Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease (PROGNOS)

Crohn's Disease

Germany
Ferring Pharmaceuticals

Terminated

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (MERMAID)

Preterm Delivery | Inadequate Milk Production

United States
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India

3

Subscribe